SMPD1 and infection: Therefore, it was shown that medications with the functional inhibition of acid sphingomyelinase (FIASMA), which inhibit ASM and reduce the formation of ceramide-enriched membrane platforms [12], decrease cell infection with SARS-CoV-2 and subsequent inflammation [12,13,14,15].